Cargando…
DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers
Patients with chronic kidney disease (CKD) exhibit an increased cancer risk compared to a healthy control population. To be able to estimate the cancer risk of the patients and to assess the impact of interventional therapies thereon, it is of particular interest to measure the patients' burden...
Autores principales: | Schupp, Nicole, Stopper, Helga, Heidland, August |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897719/ https://www.ncbi.nlm.nih.gov/pubmed/27313827 http://dx.doi.org/10.1155/2016/3592042 |
Ejemplares similares
-
Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins
por: Schupp, Nicole, et al.
Publicado: (2010) -
Effect of cryopreservation on DNA damage and DNA repair activity in human blood samples in the comet assay
por: Bankoglu, Ezgi Eyluel, et al.
Publicado: (2021) -
Differential Modulation of Markers of Oxidative Stress and DNA Damage in Arterial Hypertension
por: Kreutzmann, Moritz, et al.
Publicado: (2023) -
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
por: Magliocca, Giorgia, et al.
Publicado: (2022) -
Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
por: Rapa, Shara Francesca, et al.
Publicado: (2019)